What's in Immunitor LLC's pipeline?

Immunitor LLC has 11 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 6 in Phase 2, 2 in Phase 1.

Which companies overlap with Immunitor LLC's portfolio?

Top competitors by shared drug class: Astellas Pharma Global Development, Inc., Barbara Ensoli, MD, Bharat Biotech International Limited, Chiang Mai University, Clinical Research Organization, Dhaka, Bangladesh.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/immunitor-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Immunitor LLC — Portfolio Competitive Intelligence Brief

Immunitor LLC pipeline: 0 marketed, 0 filed, 3 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 6 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
V7	V7	phase 3	Therapeutic vaccine		Immunology / Infectious Disease
atherosclerosis vaccine	atherosclerosis vaccine	phase 3	Therapeutic vaccine	Oxidized low-density lipoprotein (oxLDL) and atherosclerotic plaque antigens	Cardiovascular
hepcortespenlisimut-L	hepcortespenlisimut-L	phase 3	Iron metabolism regulator	Hepcidin	Hematology

Therapeutic area mix

Cardiovascular · 1
Hematology · 1
Immunology / Infectious Disease · 1
Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Astellas Pharma Global Development, Inc. · 1 shared drug class
Barbara Ensoli, MD · 1 shared drug class
Bharat Biotech International Limited · 1 shared drug class
Chiang Mai University · 1 shared drug class
Clinical Research Organization, Dhaka, Bangladesh · 1 shared drug class
Cytos Biotechnology AG · 1 shared drug class
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · 1 shared drug class
ANRS, Emerging Infectious Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Immunitor LLC:

Cite this brief

Drug Landscape (2026). Immunitor LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/immunitor-llc. Accessed 2026-05-13.